These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25128116)

  • 1. Clinical efficacy of diphenylcyclopropenone in alopecia areata: retrospective data analysis of 50 patients.
    Chiang K; Atanaskova Mesinkovska N; Amoretti A; Piliang MP; Kyei A; Bergfeld WF
    J Am Acad Dermatol; 2014 Sep; 71(3):595-7. PubMed ID: 25128116
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
    Chiang KS; Mesinkovska NA; Piliang MP; Bergfeld WF
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):50-5. PubMed ID: 26551948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
    Inui S; Nakajima T; Toda N; Itami S
    J Dermatol; 2009 Jun; 36(6):323-7. PubMed ID: 19500180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
    Galadari I; Rubaie S; Alkaabi J; Galadari H
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of alopecia areata with diphenylcyclopropenone].
    Kietzmann H; Hardung H; Christophers E
    Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata--a large retrospective study on 142 patients with a self-controlled design.
    Ohlmeier MC; Traupe H; Luger TA; Böhm M
    J Eur Acad Dermatol Venereol; 2012 Apr; 26(4):503-7. PubMed ID: 21569118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
    Aghaei S
    BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone.
    van der Steen PH; van Baar HM; Happle R; Boezeman JB; Perret CM
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):227-30. PubMed ID: 2007667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of diphencyprone for the treatment of alopecia areata in children.
    Salsberg JM; Donovan J
    Arch Dermatol; 2012 Sep; 148(9):1084-5. PubMed ID: 22986874
    [No Abstract]   [Full Text] [Related]  

  • 11. Age dependence of diphenylcyclopropenone sensitization in patients with alopecia areata.
    Temesvári E; González R; Marschalkó M; Horváth A
    Contact Dermatitis; 2004 Jun; 50(6):381-2. PubMed ID: 15274737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible advantage of imiquimod and diphenylcyclopropenone combined treatment versus diphenylcyclopropenone alone: An observational study of nonresponder patients with alopecia areata.
    Wasyłyszyn T; Borowska K
    Australas J Dermatol; 2017 Aug; 58(3):219-223. PubMed ID: 27087586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
    Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
    J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical immunomodulation with diphenylcyclopropenone for alopecia areata: the Lebanese experience.
    El Khoury J; Abd-el-Baki J; Succariah F; Abbas O; Kibbi AG; Kurban M
    Int J Dermatol; 2013 Dec; 52(12):1551-6. PubMed ID: 24134785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of treatment efficacy of diphenylcyclopropenone (DPCP) for alopecia areata.
    Kutlubay Z; Sevim A; Aydın Ö; Vehid S; Serdaroğlu S
    Turk J Med Sci; 2020 Dec; 50(8):1817-1824. PubMed ID: 31655499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Home-based contact immunotherapy with diphenylcyclopropenone for alopecia areata is as effective and safe as clinic-based treatment in patients with stable disease: A retrospective study of 40 patients.
    Lee S; Lee WS
    J Am Acad Dermatol; 2018 Mar; 78(3):599-601.e1. PubMed ID: 28947296
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata.
    Luk NM; Chiu LS; Lee KC; Chau CT; Lee VW; Chang M; Lam YK; Lee HC
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e400-5. PubMed ID: 23057682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sensitization therapy in severe alopecia areata].
    Tosti A; Guerra L; Capobianco C; Brasile GP
    G Ital Dermatol Venereol; 1988 Nov; 123(11):571-3. PubMed ID: 3254331
    [No Abstract]   [Full Text] [Related]  

  • 19. Alopecia areata in children: treatment with diphencyprone.
    Schuttelaar ML; Hamstra JJ; Plinck EP; Peereboom-Wynia JD; Vuzevski VD; Mulder PG; Oranje AP
    Br J Dermatol; 1996 Oct; 135(4):581-5. PubMed ID: 8915150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alopecia areata and its treatment].
    Lammintausta K; Havu VK
    Duodecim; 1997; 113(17):1639-43. PubMed ID: 10650631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.